拉米夫定联合干扰素对慢性乙肝的疗效观察
肝炎,,肝炎,乙型,慢性;,治疗;拉米夫定;干扰素,0引言,1对象和方法,2结果,3讨论,【参考文献】
Observation of therapeutic efficacy of lamivudine combined with alpha interferon in patients with chronic hepatitis BDUAN WenBin,WANG BoLiang, ZHOU XiaoPing,ZHONG YueXia
1Department of Emergency, Tangdu Hospital,Fourth Military Medical University,Xian 710038,China, 2Department of Infection, PLA First Hospital ,Lanzhou 730030,China
【Abstract】 AIM: To study the therapeutic efficacy of lamivudine combined with alpha interferon in patients with chronic hepatitis B and to find a new approach to control the disease. METHODS: Eighty chronic hepatitis B patients with HB VDNA and HBeAg positive were divided into two groups: LAM+IFN group treated with lamivudine and alpha interferon for 12 months and LAM group treated with lamivudine alone for 12 months. RESULTS: The therapeutic effect on YMDD mutation in the group with lamivudine and IFNα1b was significantly better than that in the group with lamivudine alone(P<0.01). CONCLUSION: Lamivudine combined with alpha interferon has better therapeutic efficacy in patients with chronic hepatitis B. ......
您现在查看是摘要页,全文长 7979 字符。